Could a plasma gel heal diabetic foot ulcers faster?

NCT ID NCT06952998

Recruiting now Disease control Sponsor: Biotechnology Institute IMASD Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a gel made from a patient's own blood, called Plasma Rich in Growth Factors (PRGF), can heal foot ulcers better than standard care. It includes 38 diabetic adults with poor leg blood flow. The treatment is applied topically during regular wound care visits for up to six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Plasma Rich in Growth Factors (PRGF)
What this could lead to: If it works, this could offer a new treatment option to help heal hard-to-treat foot ulcers in diabetic patients with poor blood flow.
What could go wrong: This is a small early-phase trial with only 38 participants, so results may not apply to everyone. The treatment may not speed up healing or could cause side effects like infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOOT ULCERS, DIABETIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Foot Ulcer peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FOOT ULCERS, DIABETIC

Contacts and locations

Locations

Hospital Universitario de Basurto.
RECRUITING

Bilbao, Bizkaia, 48013, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.